The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 207 | 6,880 | SH | SOLE | 6,880 | 0 | 0 | ||
ADAMAS PHARMACEUTICALS INC | COM | 00548A106 | 1,017 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 1,641 | 28,704 | SH | SOLE | 28,704 | 0 | 0 | ||
AKEBIA THERAPEUTICS INC | COM | 00972D105 | 312 | 21,009 | SH | SOLE | 21,009 | 0 | 0 | ||
ALEXION PHARMACEUTICALS INC | COM | 015351109 | 1,143 | 9,558 | SH | SOLE | 9,558 | 0 | 0 | ||
ALEXION PHARMACEUTICALS INC | COM | 015351109 | 2,392 | 20,000 | SH | Call | SOLE | 20,000 | 0 | 0 | |
ALEXION PHARMACEUTICALS INC | COM | 015351109 | 1,794 | 15,000 | SH | Call | SOLE | 15,000 | 0 | 0 | |
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 5,471 | 43,064 | SH | SOLE | 43,064 | 0 | 0 | ||
AMGEN INC | COM | 031162100 | 1,726 | 9,924 | SH | SOLE | 9,924 | 0 | 0 | ||
ASTRAZENECA PLC | SPONSORED ADR | 046353108 | 4,164 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | ||
AVEXIS INC | COM | 05366U100 | 277 | 2,500 | SH | SOLE | 2,500 | 0 | 0 | ||
AXSOME THERAPEUTICS INC | COM | 05464T104 | 748 | 133,500 | SH | SOLE | 133,500 | 0 | 0 | ||
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 1,526 | 17,118 | SH | SOLE | 17,118 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | 1,845 | 5,793 | SH | SOLE | 5,793 | 0 | 0 | ||
BIO TECHNE CORP | COM | 09073M104 | 257 | 1,987 | SH | SOLE | 1,987 | 0 | 0 | ||
BIOVERATIV INC | COM | 09075E100 | 361 | 6,689 | SH | SOLE | 6,689 | 0 | 0 | ||
BRISTOL MYERS SQUIBB CO | COM | 110122108 | 5,515 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | ||
BRISTOL MYERS SQUIBB CO | COM | 110122108 | 2,758 | 45,000 | SH | Call | SOLE | 45,000 | 0 | 0 | |
CELGENE CORP | COM | 151020104 | 1,517 | 14,540 | SH | SOLE | 14,540 | 0 | 0 | ||
CHARLES RIV LABS INTL INC | COM | 159864107 | 236 | 2,154 | SH | SOLE | 2,154 | 0 | 0 | ||
CHECKPOINT THERAPEUTICS INC | COM | 162828107 | 438 | 112,760 | SH | SOLE | 112,760 | 0 | 0 | ||
CLOVIS ONCOLOGY INC | COM | 189464100 | 1,020 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
CONTRAFECT CORP | COM | 212326102 | 152 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
FIBROGEN INC | COM | 31572Q808 | 210 | 4,423 | SH | SOLE | 4,423 | 0 | 0 | ||
GILEAD SCIENCES INC | COM | 375558103 | 716 | 10,000 | SH | Call | SOLE | 10,000 | 0 | 0 | |
GILEAD SCIENCES INC | COM | 375558103 | 220 | 3,075 | SH | SOLE | 3,075 | 0 | 0 | ||
GLAXOSMITHKLINE PLC | SPONSORED ADR | 37733W105 | 2,128 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
GRIFOLS S A | SP ADR REP B NVT | 398438408 | 265 | 11,565 | SH | SOLE | 11,565 | 0 | 0 | ||
HERON THERAPEUTICS INC | COM | 427746102 | 287 | 15,874 | SH | SOLE | 15,874 | 0 | 0 | ||
IGNYTA INC | COM | 451731103 | 4,552 | 170,500 | SH | SOLE | 170,500 | 0 | 0 | ||
ILLUMINA INC | COM | 452327109 | 2,123 | 9,717 | SH | SOLE | 9,717 | 0 | 0 | ||
INCYTE CORP | COM | 45337C102 | 1,735 | 18,318 | SH | SOLE | 18,318 | 0 | 0 | ||
INTERCEPT PHARMACEUTICALS IN | COM | 45845P108 | 221 | 3,779 | SH | SOLE | 3,779 | 0 | 0 | ||
INTREXON CORP | COM | 46122T102 | 164 | 14,221 | SH | SOLE | 14,221 | 0 | 0 | ||
IONIS PHARMACEUTICALS INC | COM | 462222100 | 1,981 | 39,388 | SH | SOLE | 39,388 | 0 | 0 | ||
IQVIA HLDGS INC | COM | 46266C105 | 236 | 2,415 | SH | SOLE | 2,415 | 0 | 0 | ||
ISHARES TR | NASDAQ BIOTECH | 464287556 | 4,004 | 37,500 | SH | SOLE | 37,500 | 0 | 0 | ||
JUNO THERAPEUTICS INC | COM | 48205A109 | 255 | 5,588 | SH | SOLE | 5,588 | 0 | 0 | ||
KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 960 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
LILLY ELI & CO | COM | 532457108 | 1,267 | 15,000 | SH | Call | SOLE | 15,000 | 0 | 0 | |
LOXO ONCOLOGY INC | COM | 548862101 | 1,162 | 13,800 | SH | SOLE | 13,800 | 0 | 0 | ||
MEDICINES CO | COM | 584688105 | 383 | 14,000 | SH | SOLE | 14,000 | 0 | 0 | ||
MERCK & CO INC | COM | 58933Y105 | 4,710 | 83,700 | SH | SOLE | 83,700 | 0 | 0 | ||
METTLER TOLEDO INTERNATIONAL | COM | 592688105 | 2,227 | 3,594 | SH | SOLE | 3,594 | 0 | 0 | ||
NEKTAR THERAPEUTICS | COM | 640268108 | 5,498 | 92,070 | SH | SOLE | 92,070 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 326 | 4,204 | SH | SOLE | 4,204 | 0 | 0 | ||
NEW SR INVT GROUP INC | COM | 648691103 | 316 | 41,850 | SH | SOLE | 41,850 | 0 | 0 | ||
PACIRA PHARMACEUTICALS INC | COM | 695127100 | 1,141 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
PARATEK PHARMACEUTICALS INC | COM | 699374302 | 716 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
PFIZER INC | COM | 717081103 | 4,068 | 112,300 | SH | SOLE | 112,300 | 0 | 0 | ||
PROGENICS PHARMACEUTICALS IN | COM | 743187106 | 130 | 21,782 | SH | SOLE | 21,782 | 0 | 0 | ||
PROSHARES TR | PSHS ULT NASB | 74347R214 | 7,317 | 130,500 | SH | SOLE | 130,500 | 0 | 0 | ||
RECRO PHARMA INC | COM | 75629F109 | 233 | 25,231 | SH | SOLE | 25,231 | 0 | 0 | ||
REGENERON PHARMACEUTICALS | COM | 75886F107 | 1,532 | 4,076 | SH | SOLE | 4,076 | 0 | 0 | ||
SPDR SERIES TRUST | S&P BIOTECH | 78464A870 | 5,517 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | ||
SAGE THERAPEUTICS INC | COM | 78667J108 | 11,694 | 71,000 | SH | Put | SOLE | 71,000 | 0 | 0 | |
SCYNEXIS INC | COM | 811292101 | 155 | 66,608 | SH | SOLE | 66,608 | 0 | 0 | ||
SEATTLE GENETICS INC | COM | 812578102 | 1,908 | 35,668 | SH | SOLE | 35,668 | 0 | 0 | ||
TESARO INC | COM | 881569107 | 414 | 5,000 | SH | SOLE | 5,000 | 0 | 0 | ||
ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | 393 | 8,472 | SH | SOLE | 8,472 | 0 | 0 | ||
UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 303 | 2,050 | SH | SOLE | 2,050 | 0 | 0 | ||
VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 2,494 | 16,639 | SH | SOLE | 16,639 | 0 | 0 | ||
ALKERMES PLC | SHS | G01767105 | 2,395 | 43,763 | SH | SOLE | 43,763 | 0 | 0 | ||
PROQR THRAPEUTICS N V | SHS EURO | N71542109 | 992 | 307,692 | SH | SOLE | 307,692 | 0 | 0 | ||
QIAGEN NV | SHS NEW | N72482123 | 1,746 | 56,445 | SH | SOLE | 56,445 | 0 | 0 |